DocDollars

Otsuka Pharmaceutical Co., Ltd.

Japan · Reporting entity ID 100000000112

Total reported 2019–2025
$59.0M
#149 of 2,960 reporting companies — 0.1% of all reported industry payments
$2.62M in general payments across 862 records, plus $56.4M in research funding across 4,951 records.

How it breaks down

General payments $2,620,706
Research funding $56,351,002

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Otsuka Pharmaceutical Co., Ltd. reported $59.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #149 of 2,960 reporting companies. 96% of that was research funding and 4% general payments such as consulting, speaking, food and travel. 862 general payment records and 4,951 research records were filed.

Common questions about Otsuka Pharmaceutical Co., Ltd.

How much has Otsuka Pharmaceutical Co., Ltd. paid US doctors?

Otsuka Pharmaceutical Co., Ltd. reported $58,971,708 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,620,706 in general payments, $56,351,002 in research funding.

How does Otsuka Pharmaceutical Co., Ltd. rank among drug and device companies?

It ranks #149 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Otsuka Pharmaceutical Co., Ltd. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.